Expression of peroxisome proliferator-activated receptor 酌 in rat retina during development 窑 Basic Research 窑

AIM To evaluate the spatiotemporal expression pattern of PPARγ in embryonic and early postnatal stages of rat retina. METHODS Fetal rats were collected at 13-18d of gestation (GD) from pregnant females and postnatal rats at 1d (P1) and 5d (P5) after birth were also used. We used RT-PCR to detect PPARγ mRNA and immunohistochemical to observe PPARγ protein. And at last, we chose HE staining showed the structural changes of rat retina during development. RESULTS RT-PCR analysis showed that PPARγ mRNA was expressed as early as GD13 and gradually decreased as maturation continued. However, the PPARγ gene expression significantly increased after birth, especially in P5. Immunohistochemical analysis showed PPARγ protein was expressed throughout the retinal neuroepithelium at GD13 and GD14, and then decreased during late embryogenesis but remained relatively high in the predicted ganglion cell zone. During postnatal development, PPARγ protein was remarkably increased and the positive signals were mainly located in nerve fiber layer (NFL), ganglion cell layer (GCL) and outer layers of the retina. CONCLUSION The spatiotemporal changes of PPARγ expression demonstrated that PPARγ might play a role in regulating the differentiation and maturation of retinal cells.

[1]  M. Emborg,et al.  Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γ Agonist against MPTP , 2013, PPAR research.

[2]  C. Chen,et al.  The Role of Peroxisome Proliferator-Activated Receptor and Effects of Its Agonist, Pioglitazone, on a Rat Model of Optic Nerve Crush: PPARγ in Retinal Neuroprotection , 2013, PloS one.

[3]  W. Ye,et al.  Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats. , 2013, Investigative ophthalmology & visual science.

[4]  B. Cong,et al.  Expression patterns of Nurr1 in rat retina development , 2012, Journal of Molecular Histology.

[5]  C. Wei,et al.  Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway , 2011, Neuroscience.

[6]  F. Schweighoffer,et al.  Differential effects of PPARgamma ligands on oxidative stress-induced death of retinal pigmented epithelial cells. , 2011, Investigative ophthalmology & visual science.

[7]  Lois E. H. Smith,et al.  Short Communication: PPAR&ggr; Mediates a Direct Antiangiogenic Effect of &ohgr;3-PUFAs in Proliferative Retinopathy , 2010, Circulation research.

[8]  T. Herdegen,et al.  Peroxisome-proliferator-activated receptors γ and peroxisome-proliferator-activated receptors β/δ and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain , 2010, Journal of hypertension.

[9]  G. Miglio,et al.  PPARγ stimulation promotes neurite outgrowth in SH-SY5Y human neuroblastoma cells , 2009, Neuroscience Letters.

[10]  J. Roider,et al.  Triamcinolone acetonide prevents oxidative stress-induced tight junction disruption of retinal pigment epithelial cells , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[11]  Y. Yun,et al.  Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. , 2004, Experimental cell research.

[12]  A. Smith,et al.  Neural differentiation of mouse embryonic stem cells. , 2001, Biochemical Society transactions.

[13]  L. Domenjoud,et al.  Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease. , 2000, The International journal of developmental biology.

[14]  H P Koeffler,et al.  Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. , 1998, Cancer research.

[15]  Christopher K. Glass,et al.  The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.

[16]  J. Auwerx,et al.  The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene* , 1997, The Journal of Biological Chemistry.

[17]  J. Auwerx,et al.  Peroxisome proliferator-activated receptors, orphans with ligands and functions. , 1997, Current opinion in lipidology.

[18]  J Auwerx,et al.  PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene. , 1996, The EMBO journal.

[19]  K. Umesono,et al.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. J. Ross,et al.  Peroxisome Proliferator-Activated Receptor Expression in Murine Models and Humans with Age-related Macular Degeneration. , 2009, The open biology journal.

[21]  J. Yi,et al.  Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. , 2008, Frontiers in bioscience : a journal and virtual library.

[22]  T. Mayumi,et al.  Peroxisome Proliferator-activated Receptor -mediated Regulation of Neural Stem Cell Proliferation , 2006 .

[23]  K. Houseknecht,et al.  Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review. , 2002, Domestic animal endocrinology.

[24]  W. Wahli,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Differential Expression of Peroxisome Proliferator- Activated Receptor-�,-�, and- � during Rat , 2022 .

[25]  W. Wahli,et al.  Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. , 1996, Endocrinology.

[26]  B. Blumberg,et al.  Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. , 1995, Gene expression.